AI Product

Tempus AI — Healthcare Technology

Precision medicine platform combining clinical and molecular data, AI analytics, and decision-support tools for oncology and broader therapeutic areas, used…

Intelligence Summary

Product
  • Active
  • Verified public sources
  • Developer Tempus AI
  • Category Healthcare Technology
  • Status Active
  • Latest update 2015: Tempus founded in Chicago by Eric Lefkofsky, who serves as chief executive officer.
  • Documentation Official page
  • Last reviewed Jul 2026
6 Technologies

Official product page

Target customer

Health systems, oncologists, researchers, and pharmaceutical companies seeking data-driven insights for treatment selection, trial matching, and drug development.

Features & capabilities

Industries: AI in Healthcare; Healthcare Technology

Related reports

Related insights

Overview

Precision medicine platform combining clinical and molecular data, AI analytics, and decision-support tools for oncology and broader therapeutic areas, used by health systems, researchers, and life-sciences partners.

Product and company

Tempus AI — Healthcare Technology is a verified product offering linked to the Brel Digital company profile for Tempus AI.

Use cases

Precision medicine platform combining clinical and molecular data, AI analytics, and decision-support tools for oncology and broader therapeutic areas, used by health systems, researchers, and life-sciences partners.

Target customer

Health systems, oncologists, researchers, and pharmaceutical companies seeking data-driven insights for treatment selection, trial matching, and drug development.

Technologies

Primary technologies assigned from the linked company profile: Clinical Documentation, Deep Learning, Healthcare Analytics, Machine Learning, Medical Imaging, Predictive Analytics.

Sources and references

  • Official product / company source: https://www.tempus.com/news/pr/tempus-announces-strategic-collaboration-agreement-with-merck-to-accelerate-ai-driven-precision-medicine/
  • Supporting source: https://www.tempus.com

Product facts are limited to information already verified on the linked Brel company profile and its cited official URLs. No speculative capabilities are added.

Last reviewed

This product profile was last reviewed on 2026-07-14.

Correction request

If this product record is inaccurate or outdated, submit a correction through Brel Digital’s Corrections Policy.

Features and capabilities

  • Precision medicine platform combining clinical and molecular data, AI analytics, and decision-support tools for oncology
  • clinical
  • molecular data
  • AI analytics
  • and decision-support tools for oncology
  • broader therapeutic areas
  • used by health systems
  • researchers

Extracted from the linked company product description already verified on Brel. No capabilities were invented.

Sources and references

This article draws on publicly available company information, official websites, filings, interviews, announcements, and other cited sources. Information may change over time.

Enquire about this product profile

Messages are delivered to contact@breldigital.com.